Advertisement

Why Quanterix Shares Plunged by Nearly 55% Today

A slide in revenue, a deepening net loss, and dispiriting guidance were the stimuli behind the monster drop in Quanterix (NASDAQ: QTRX) stock on Tuesday. After the biotech reported its second-quarter results following market hours Monday -- and announced a high-level departure within its ranks -- investors traded the shares aggressively, with the stock losing over half its value. The quarter saw Quanterix earn $23.5 million in total revenue, for a year-over-year decline of more than 7%.